An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Egile nagusia: | Bristy, Israt Zerin |
---|---|
Beste egile batzuk: | Kabir, Md. Tanvir |
Formatua: | Thesis |
Hizkuntza: | English |
Argitaratua: |
Brac University
2021
|
Gaiak: | |
Sarrera elektronikoa: | http://hdl.handle.net/10361/15619 |
Antzeko izenburuak
-
Molecules associated with the development of lung cancer
nork: Rahman, Adree, et al.
Argitaratua: (2023) -
A case study of lung cancer patients in term of various risk factors in context of Bangladesh
nork: Shabnam, Musharrat
Argitaratua: (2018) -
Immunotherapy in the Management of Lung Cancer
nork: Tasnim, Humayra
Argitaratua: (2022) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
nork: Paul, Pulock
Argitaratua: (2024) -
Potential of liposomes for the treatment of lung cancer- a review
nork: Mim, Shanzida
Argitaratua: (2023)